Reliability and validity of an instrument for assessing patients' perceptions about medications for diabetes: The PAM-D

Patrick O. Monahan, Kathleen A. Lane, Risa P. Hayes, Colleen A. McHorney, David G. Marrero

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Purpose: To evaluate the reliability and validity of the Perceptions About Medications for Diabetes (PAM-D) instrument. Methods: The item pool was generated from a literature review and 18 focus groups of Type 2 diabetes patients. Surveys were mailed to 1,000 low-income diabetes patients; 362 were returned; 65 of 100 re-test surveys were returned. Results: This paper uses data from 343 Type 2 respondents. Mean age and age diagnosed were 59 and 48, respectively; 72% female; 52% African American; 51% were taking oral antihyperglycemic agents [OHA] monotherapy, 18% insulin monotherapy, and 28% insulin plus OHA. The initial 66 items were reduced to 37 across nine scales: scheduling flexibility, portability convenience, regimen inconvenience, medication effectiveness, difficulty remembering medications, gastrointestinal, hypoglycemia-related, and weight/edema physical side effects, and emotional side effects. Scale reliabilities ranged from 0.71 to 0.92 (coefficient alpha) and from 0.54 to 0.83 (test-retest coefficient, 37-81-day interval); factor loadings ranged from 0.35 to 0.86 (median, 0.67); significant scale differences across medication groups (insulin, OHA, insulin plus OHA) were consistent with a priori hypotheses. Conclusions: The PAM-D has substantial reliability and validity in a low-income, inner-city population of Type 2 diabetes patients and may be valuable for understanding multidimensional perceptions driving patients' treatment preferences.

Original languageEnglish (US)
Pages (from-to)941-952
Number of pages12
JournalQuality of Life Research
Volume18
Issue number7
DOIs
StatePublished - Sep 1 2009

Fingerprint

Hypoglycemic Agents
Reproducibility of Results
Insulin
Type 2 Diabetes Mellitus
Patient Preference
Focus Groups
Hypoglycemia
African Americans
Edema
Weights and Measures
Population
Surveys and Questionnaires
Therapeutics

Keywords

  • Diabetes
  • Medication perceptions
  • Patient satisfaction
  • Patient-reported outcomes
  • Psychometrics
  • Validation studies

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Reliability and validity of an instrument for assessing patients' perceptions about medications for diabetes : The PAM-D. / Monahan, Patrick O.; Lane, Kathleen A.; Hayes, Risa P.; McHorney, Colleen A.; Marrero, David G.

In: Quality of Life Research, Vol. 18, No. 7, 01.09.2009, p. 941-952.

Research output: Contribution to journalArticle

@article{7592d888e4bd4333b9f586c04dc18df7,
title = "Reliability and validity of an instrument for assessing patients' perceptions about medications for diabetes: The PAM-D",
abstract = "Purpose: To evaluate the reliability and validity of the Perceptions About Medications for Diabetes (PAM-D) instrument. Methods: The item pool was generated from a literature review and 18 focus groups of Type 2 diabetes patients. Surveys were mailed to 1,000 low-income diabetes patients; 362 were returned; 65 of 100 re-test surveys were returned. Results: This paper uses data from 343 Type 2 respondents. Mean age and age diagnosed were 59 and 48, respectively; 72{\%} female; 52{\%} African American; 51{\%} were taking oral antihyperglycemic agents [OHA] monotherapy, 18{\%} insulin monotherapy, and 28{\%} insulin plus OHA. The initial 66 items were reduced to 37 across nine scales: scheduling flexibility, portability convenience, regimen inconvenience, medication effectiveness, difficulty remembering medications, gastrointestinal, hypoglycemia-related, and weight/edema physical side effects, and emotional side effects. Scale reliabilities ranged from 0.71 to 0.92 (coefficient alpha) and from 0.54 to 0.83 (test-retest coefficient, 37-81-day interval); factor loadings ranged from 0.35 to 0.86 (median, 0.67); significant scale differences across medication groups (insulin, OHA, insulin plus OHA) were consistent with a priori hypotheses. Conclusions: The PAM-D has substantial reliability and validity in a low-income, inner-city population of Type 2 diabetes patients and may be valuable for understanding multidimensional perceptions driving patients' treatment preferences.",
keywords = "Diabetes, Medication perceptions, Patient satisfaction, Patient-reported outcomes, Psychometrics, Validation studies",
author = "Monahan, {Patrick O.} and Lane, {Kathleen A.} and Hayes, {Risa P.} and McHorney, {Colleen A.} and Marrero, {David G.}",
year = "2009",
month = "9",
day = "1",
doi = "10.1007/s11136-009-9510-2",
language = "English (US)",
volume = "18",
pages = "941--952",
journal = "Quality of Life Research",
issn = "0962-9343",
publisher = "Springer Netherlands",
number = "7",

}

TY - JOUR

T1 - Reliability and validity of an instrument for assessing patients' perceptions about medications for diabetes

T2 - The PAM-D

AU - Monahan, Patrick O.

AU - Lane, Kathleen A.

AU - Hayes, Risa P.

AU - McHorney, Colleen A.

AU - Marrero, David G.

PY - 2009/9/1

Y1 - 2009/9/1

N2 - Purpose: To evaluate the reliability and validity of the Perceptions About Medications for Diabetes (PAM-D) instrument. Methods: The item pool was generated from a literature review and 18 focus groups of Type 2 diabetes patients. Surveys were mailed to 1,000 low-income diabetes patients; 362 were returned; 65 of 100 re-test surveys were returned. Results: This paper uses data from 343 Type 2 respondents. Mean age and age diagnosed were 59 and 48, respectively; 72% female; 52% African American; 51% were taking oral antihyperglycemic agents [OHA] monotherapy, 18% insulin monotherapy, and 28% insulin plus OHA. The initial 66 items were reduced to 37 across nine scales: scheduling flexibility, portability convenience, regimen inconvenience, medication effectiveness, difficulty remembering medications, gastrointestinal, hypoglycemia-related, and weight/edema physical side effects, and emotional side effects. Scale reliabilities ranged from 0.71 to 0.92 (coefficient alpha) and from 0.54 to 0.83 (test-retest coefficient, 37-81-day interval); factor loadings ranged from 0.35 to 0.86 (median, 0.67); significant scale differences across medication groups (insulin, OHA, insulin plus OHA) were consistent with a priori hypotheses. Conclusions: The PAM-D has substantial reliability and validity in a low-income, inner-city population of Type 2 diabetes patients and may be valuable for understanding multidimensional perceptions driving patients' treatment preferences.

AB - Purpose: To evaluate the reliability and validity of the Perceptions About Medications for Diabetes (PAM-D) instrument. Methods: The item pool was generated from a literature review and 18 focus groups of Type 2 diabetes patients. Surveys were mailed to 1,000 low-income diabetes patients; 362 were returned; 65 of 100 re-test surveys were returned. Results: This paper uses data from 343 Type 2 respondents. Mean age and age diagnosed were 59 and 48, respectively; 72% female; 52% African American; 51% were taking oral antihyperglycemic agents [OHA] monotherapy, 18% insulin monotherapy, and 28% insulin plus OHA. The initial 66 items were reduced to 37 across nine scales: scheduling flexibility, portability convenience, regimen inconvenience, medication effectiveness, difficulty remembering medications, gastrointestinal, hypoglycemia-related, and weight/edema physical side effects, and emotional side effects. Scale reliabilities ranged from 0.71 to 0.92 (coefficient alpha) and from 0.54 to 0.83 (test-retest coefficient, 37-81-day interval); factor loadings ranged from 0.35 to 0.86 (median, 0.67); significant scale differences across medication groups (insulin, OHA, insulin plus OHA) were consistent with a priori hypotheses. Conclusions: The PAM-D has substantial reliability and validity in a low-income, inner-city population of Type 2 diabetes patients and may be valuable for understanding multidimensional perceptions driving patients' treatment preferences.

KW - Diabetes

KW - Medication perceptions

KW - Patient satisfaction

KW - Patient-reported outcomes

KW - Psychometrics

KW - Validation studies

UR - http://www.scopus.com/inward/record.url?scp=69249213447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69249213447&partnerID=8YFLogxK

U2 - 10.1007/s11136-009-9510-2

DO - 10.1007/s11136-009-9510-2

M3 - Article

C2 - 19609723

AN - SCOPUS:69249213447

VL - 18

SP - 941

EP - 952

JO - Quality of Life Research

JF - Quality of Life Research

SN - 0962-9343

IS - 7

ER -